Stay updated on MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial

Sign up to get notified when there's something new on the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Squamous cell carcinoma of the head and neck as a listed condition and included the Genetic and Rare Diseases Information Center as a resources link.
    Difference
    0.1%
    Check dated 2026-04-02T15:34:09.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-19T06:08:58.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:54:33.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the previous funding-status notice (Revision: v3.4.1); these are site-wide maintenance updates and do not affect the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:20:09.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    A funding/status notice was added about government funding and the page version was updated to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:41:10.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated the label 'Last Update Submitted that Met QC Criteria'. Standardized capitalization for 'No FEAR Act' and updated the revision from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T04:25:45.000Z thumbnail image

Stay in the know with updates to MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page.